Publication | Closed Access

Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds: Two-year clinical outcomes of the EVERBIO II trial

Percutaneous Coronary InterventionBiolimus-eluting Coronary StentsCardiovascular Translational ResearchCardiovascular DiseaseVascular SurgeryCardiologyVascular BiologyTwo-year Clinical OutcomesAcute Myocardial InfarctionBiomedical EngineeringMedicineAtherosclerosisEverbio Ii TrialCoronary Artery DiseaseMyocardial Infarction